KRAS and colorectal adenocarcinoma: Although KRAS4A is dispensable for mouse development [19], accumulating evidences indicate that the altered KRAS4A/4B ratios may correlate with progression of lung and colorectal adenocarcinoma [20, 21] and that KRAS4A plays an important role in lung carcinogenesis [22].